Yidu Tech Inc.（2158.HK）股價、財務與研究

盤中時間採用HKT。市場資料可能有所延遲。

公司概況

Yidu Tech Inc. is a technology company that develops and deploys healthcare solutions leveraging big data and artificial intelligence. Its operations extend across Mainland China, Brunei, and other global regions. The company's business activities are categorized into four core segments: Big Data Platform and Solutions, Life Sciences Solutions, Health Management Platform and Solutions, and a segment for Other ventures. The Big Data Platform and Solutions division provides sophisticated data intelligence platforms and analytics-driven solutions. These offerings cater to hospitals, diverse healthcare institutions, regulatory bodies, and policymakers, aiming to enhance research, clinical diagnosis and treatment, and operational efficiency. This segment specifically includes the provision of DPAP/Eywa platforms for medical organizations. Through its Life Sciences Solutions segment, the company delivers analytical services that support clinical development, real-world evidence (RWE) research, and digital commercialization strategies for pharmaceutical companies, biotechnology firms, and medical device manufacturers. The Health Management Platform and Solutions segment offers health management applications and services, as well as insurance technology (InsurTech) solutions for insurance companies, agencies, and relevant regulators. This segment also includes the distribution of insurance products and the sale of pharmaceuticals and associated hardware. The Others segment encompasses the sale of computer hardware, medical devices, insurance brokerage services, and engagement in medical and computer technology development. Yidu Tech Inc. was established in 2014 and is headquartered in Beijing, China.

產業: Medical - Healthcare Information Services
部門: Healthcare
總部: CN
執行長: Jiming Xu
上市以來: 2021年1月15日
僱員: 754

市場位置

日內區間

目前HK$3.815，

HK$3.74HK$3.905

52週區間

目前HK$3.815，

HK$3.745HK$7.22

開盤價: HK$3.885
前收盤價: HK$3.875
成交量: 2240.87萬; 3.2× 平均值
平均成交量: 699.73萬; 日均成交量
市值: 38.9億 HKD
貝塔: 1.3; 市場參考 1
50天平均值: HK$4.7341; 低於平均水平-19.41%
200天平均值: HK$5.3811; 低於平均水平-29.10%

財務數據

財務快照

估值與收益率

企業價值: 39.27億 CNY
本益比（TTM）: 49.78×
股價淨值比（TTM）: 0.97×
股價營收比（TTM）: 4.12×
EV/EBITDA: -71.59×
盈餘收益率: 1.55%
自由現金流收益率: -1.14%
股息率: 0.00%

獲利能力和效率

毛利率: 36.44%
營業利益率: 1.50%
淨利潤率: 8.74%
股東權益報酬率: 1.93%
資產報酬率: 1.63%
投入資本報酬率: -2.25%

財務健康

負債權益比: 0.02×
流動比率: 4.81×
奧特曼 Z 分數: 1.07
皮奧特羅斯基 F 分數: 0 共 9 個

財務報表

利潤率趨勢

獲利能力占已公布營收的百分比。

毛利率營業利益率淨利潤率

損益趨勢

營收

7.91億 CNY+10.56%

營業利益

−9027.69萬 CNY+32.70%

淨利

7015.46萬 CNY+1.88億 CNY

項目（CNY）	2025會計年度	2024會計年度	2023會計年度	2022會計年度	2021會計年度
營收	7.91億 CNY	7.15億 CNY	8.07億 CNY	8.05億 CNY	12.37億 CNY
銷貨成本	5.03億 CNY	4.76億 CNY	4.68億 CNY	5.3億 CNY	8.4億 CNY
毛利	2.88億 CNY	2.39億 CNY	3.39億 CNY	2.75億 CNY	3.97億 CNY
研究與開發	1.59億 CNY	1.86億 CNY	2.33億 CNY	3.43億 CNY	3.69億 CNY
銷售、一般及管理費用	1.91億 CNY	2.86億 CNY	3.8億 CNY	5.04億 CNY	7.51億 CNY
營業費用	3.78億 CNY	3.73億 CNY	5.59億 CNY	9.8億 CNY	11.65億 CNY
利息收入	169.72萬 CNY	1.59億 CNY	1.43億 CNY	7876.3萬 CNY	551.4萬 CNY
利息支出	186.89萬 CNY	201.2萬 CNY	331.1萬 CNY	261.1萬 CNY	421.3萬 CNY
折舊和攤銷	3541.93萬 CNY	4329.6萬 CNY	4711.4萬 CNY	4635.1萬 CNY	4693.8萬 CNY
營業利益	−9027.69萬 CNY	−1.34億 CNY	−2.2億 CNY	−6.18億 CNY	−7.6億 CNY
淨利	7015.46萬 CNY	−1.18億 CNY	−1.95億 CNY	−6.28億 CNY	−7.62億 CNY